W. David

A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil

T. Fullerton, M. Delnomdedieu, J. Mancuso, 2018, Alzheimer's Research & Therapy.

In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects

P. Fazio, O. Vitolo, C. Halldin, 2017, Neuropharmacology.

A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil

T. Fullerton, M. Delnomdedieu, J. Mancuso, 2016, Alzheimer's Research & Therapy.